Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 113, Issue 41, Pages E6145-E6152
Publisher
Proceedings of the National Academy of Sciences
Online
2016-09-27
DOI
10.1073/pnas.1607843113
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor
- (2016) Veit Rothhammer et al. NATURE MEDICINE
- CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands
- (2016) Bruno Lamas et al. NATURE MEDICINE
- AHR Function in Lymphocytes: Emerging Concepts
- (2016) Liang Zhou TRENDS IN IMMUNOLOGY
- Ultraviolet light converts propranolol, a nonselective β-blocker and potential lupus-inducing drug, into a proinflammatory AhR ligand
- (2015) Karim Dorgham et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Laquinimod ameliorates spontaneous colitis in interleukin-10-gene-deficient mice with improved barrier function
- (2015) Jing Sun et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α
- (2015) Ivan D Mascanfroni et al. NATURE MEDICINE
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- Aryl hydrocarbon receptor: Linking environment to immunity
- (2015) Marina Cella et al. SEMINARS IN IMMUNOLOGY
- Laquinimod, an up-and-coming immunomodulatory agent for treatment of multiple sclerosis
- (2014) Michel Varrin-Doyer et al. EXPERIMENTAL NEUROLOGY
- Aryl Hydrocarbon Receptor Repressor and TiPARP (ARTD14) Use Similar, but also Distinct Mechanisms to Repress Aryl Hydrocarbon Receptor Signaling
- (2014) Laura MacPherson et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Laquinimod exerts strong clinical and immunomodulatory effects in Lewis rat experimental autoimmune neuritis
- (2014) Kalliopi Pitarokoili et al. JOURNAL OF NEUROIMMUNOLOGY
- A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis
- (2014) T. L. Vollmer et al. JOURNAL OF NEUROLOGY
- The Aryl Hydrocarbon Receptor: Differential Contribution to T Helper 17 and T Cytotoxic 17 Cell Development
- (2014) Mark D. Hayes et al. PLoS One
- voom: precision weights unlock linear model analysis tools for RNA-seq read counts
- (2014) Charity W Law et al. GENOME BIOLOGY
- Aryl Hydrocarbon Receptor and Kynurenine: Recent Advances in Autoimmune Disease Research
- (2014) Nam Trung Nguyen et al. Frontiers in Immunology
- Immunological Relevance of the Coevolution of IDO1 and AHR
- (2014) Merja Jaronen et al. Frontiers in Immunology
- Laquinimod reduces neuroaxonal injury through inhibiting microglial activation
- (2014) Manoj Kumar Mishra et al. Annals of Clinical and Translational Neurology
- featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
- (2013) Y. Liao et al. BIOINFORMATICS
- Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis
- (2013) Valérie Jolivel et al. BRAIN
- The roles of aryl hydrocarbon receptor in immune responses
- (2013) Nam Trung Nguyen et al. INTERNATIONAL IMMUNOLOGY
- Cross-talk between Aryl Hydrocarbon Receptor and the Inflammatory Response
- (2013) Christoph F. A. Vogel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage
- (2013) M. Filippi et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Differential Influences of the Aryl Hydrocarbon Receptor on Th17 Mediated Responses in vitro and in vivo
- (2013) João H. Duarte et al. PLoS One
- Regulation of central nervous system autoimmunity by the aryl hydrocarbon receptor
- (2013) Francisco J. Quintana Seminars in Immunopathology
- Laquinimod Delays and Suppresses Nephritis in Lupus-Prone Mice and Affects Both Myeloid and Lymphoid Immune Cells
- (2013) Elaine V. Lourenço et al. Arthritis & Rheumatology
- Therapeutic laquinimod treatment decreases inflammation, initiates axon remyelination, and improves motor deficit in a mouse model of multiple sclerosis
- (2013) Spencer Moore et al. Brain and Behavior
- Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination
- (2012) Wolfgang Brück et al. ACTA NEUROPATHOLOGICA
- Kinetics of Proinflammatory Monocytes in a Model of Multiple Sclerosis and Its Perturbation by Laquinimod
- (2012) Manoj K. Mishra et al. AMERICAN JOURNAL OF PATHOLOGY
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- GENCODE: The reference human genome annotation for The ENCODE Project
- (2012) J. Harrow et al. GENOME RESEARCH
- Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis
- (2012) Rina Aharoni et al. JOURNAL OF NEUROIMMUNOLOGY
- Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis
- (2012) Francesca Ruffini et al. Multiple Sclerosis Journal
- Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
- (2012) Giancarlo Comi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity
- (2012) Ulf Schulze-Topphoff et al. PLoS One
- Modulation of Autoimmune Demyelination by Laquinimod via Induction of Brain-Derived Neurotrophic Factor
- (2011) Jan Thöne et al. AMERICAN JOURNAL OF PATHOLOGY
- In Vivo Induction of Tr1 Cells via Mucosal Dendritic Cells and AHR Signaling
- (2011) Henry Yim Wu et al. PLoS One
- Exactly the Same but Different: Promiscuity and Diversity in the Molecular Mechanisms of Action of the Aryl Hydrocarbon (Dioxin) Receptor
- (2011) Michael S. Denison et al. TOXICOLOGICAL SCIENCES
- Hepatic transcriptomic responses to TCDD in dioxin-sensitive and dioxin-resistant rats during the onset of toxicity
- (2011) Paul C. Boutros et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis
- (2010) Christiane Wegner et al. JOURNAL OF NEUROIMMUNOLOGY
- The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27
- (2010) Lionel Apetoh et al. NATURE IMMUNOLOGY
- Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell–like and Foxp3+ regulatory T cells
- (2010) Roopali Gandhi et al. NATURE IMMUNOLOGY
- An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis
- (2010) F. J. Quintana et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor
- (2008) Francisco J. Quintana et al. NATURE
- Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells
- (2008) A. Kimura et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search